* Ugur Shaheen, Chairman of the Board of Directors of the Biotech Company for Biotechnology and Vaccines, which has discovered the Corona virus vaccine affiliated with Pfizer of the United States, confirmed working with a number of institutions and organizations to provide the vaccine to poor countries, indicating the need to produce sufficient quantities of the vaccine to reach all parts of the world because  This is one of our main goals.

 * In response to a question about the effectiveness of the vaccine, Ujur Shaheen added, in statements to medical newspapers and magazines, "So far we have some priority data regarding the effectiveness of the vaccine. We found that the vaccine prevents infection with the virus in more than 90% of the people who received the vaccine, and we will receive more."  The data during the next two weeks to get more details about the possibility of protecting the elderly, and we have data on primary protection, but we consider that the vaccine may remain stable in its effectiveness for a year, but that requires lengthy studies to evaluate this.

 * Regarding the safety characteristics of the vaccine, he said: "It appears that it is good and a very small percentage suffer from some low and medium side effects, such as high temperatures, and this is normal in the vaccine.

 * On preventing age groups from the vaccine, he said: It is important that the vaccine in the first stage reaches the most vulnerable people, such as medical staff and the elderly, but we must wait some time for the vaccine to become available all over the world, and we consider that 2021 will be necessary from  In order to secure more doses, there will be other companies that will provide effective vaccines, and if we cooperate with each other we can supply huge quantities of vaccines.

 * Regarding what was reported about the start of vaccine production before Corona was considered a pandemic, he said: Yes, in January we learned that this virus contains characteristics that make it vulnerable to becoming a global pandemic, and thus the spread of the virus in China was in a densely populated city, and one of the main centers for planes and trains.

 * Regarding the price of the vaccine, according to the price that was announced, which is $ 20, he said: “It is the price of the industrial field and depends on the number of doses that are secured. And when we provide this vaccine to countries experiencing economic difficulties, we will take into account the need to reduce the price, and no  A specific price for all different countries, and we will work on this part in the coming months.